Reuters logo
BRIEF-Genmab signs research deal with Japan's Kyowa Hakko Kirin
December 5, 2012 / 7:01 AM / 5 years ago

BRIEF-Genmab signs research deal with Japan's Kyowa Hakko Kirin

COPENHAGEN, Dec 5 (Reuters) - Danish biotech company Genmab A/S said on Wednesday: * Has entered into duobody platform collaboration with Japan’s Kyowa Hakko Kirin * Collaboration is to create bispecific antibodies using Genmab’s DuoBody technology * If successful, the parties may decide to enter into a license agreement to develop a new DuoBody product * The financial terms of the agreement have not been disclosed, deal will not have a material impact on Genmab’s 2012 financial guidance

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below